Quality of life and cancer-related needs in patients with choroidal melanoma

British Journal of Ophthalmology

Volumn 97, Issue 11, 2013, Pages 1471-1474

  Wiley, Joshua F ^a   Laird, Kelsey ^a   Beran, Tammy ^a   McCannel, Tara A ^a,b,c   Stanton, Annette L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHOROID MELANOMA; COMORBIDITY; DEMOGRAPHY; DEPRESSION; ENUCLEATION; FEMALE; HEALTH CARE NEED; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; UNITED STATES; UNIVERSITY; VISUAL ACUITY;

CANCER; CHOROID NEOPLASMS; QUALITY OF LIFE;

ADULT; AGED; AGED, 80 AND OVER; CHOROID NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOS ANGELES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVAL RATE; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 84888641841     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303635     Document Type: Article

References (19)

1. Damato B. Developments in the management of uveal melanoma. Clin Experiment Ophthalmol 2004;32:639-47. (Pubitemid 40074112)
2. Brandberg Y, Kock E, Oskar K, et al. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study. Eye 2000;14:839-46. (Pubitemid 32040869)
3. Chabert S, Velikay-Parel M, Zehetmayer M. Influence of uveal melanoma therapy on patients' quality of life: a psychological study. Acta Ophthalmol Scand 2004;82:25-31. (Pubitemid 38228658)
4. Collaborative Ocular Melanoma Study-Quality of Life Study Group. Quality of life after iodine 125 Brachytherapy vs Enucleation for choroidal melanoma: 5-year results from the collaborative ocular melanoma study: COMS QOLS report no. 3. Arch Ophthalmol 2006;124:226-38.
5. Cruickshanks KJ, Fryback DG, Nondahl DM, et al. Treatment choice and quality of life in patients with choroidal melanoma. Arch Ophthalmol 1999;117:461-67. (Pubitemid 29169640)
6. Reimer J, Esser J, Fleiss A, et al. Quality of life in patients with malignant choroidal melanoma after radiotherapy. Graefe's Arch Clin Exp Ophthalmol 2003;241:371-77. (Pubitemid 36748572)
7. Reimer J, Voigtlaender-Fleiss A, Karow A, et al. The impact of diagnosis and plaque radiotherapy treatment of malignant choroidal melanoma on patients' quality of life. Psychooncology 2006;15:1077-85. (Pubitemid 46040595)
8. The Collaborative Ocular Melanoma Study-Quality of Life Study Group&z.ast;. Development and validation of disease-specific measures for choroidal melanoma: COMS-QOLS report no. 2. Arch Ophthalmol 2003;121:1010-20.
9. Crawford JR, Henry JD, Crombie C, et al. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 2001;40:429-34. (Pubitemid 33080898)
10. Beran TM, McCannel TA, Stanton AL, et al. Reactions to and desire for prognostic testing in choroidal melanoma patients. J Genet Couns 2009;18:265-74.
11. Lattimore-Foot GG. Needs assessment in tertiary and secondary oncology practice: a conceptual and methodological exposition. University of Newcastle, 1996.
12. Cossich T, Scho field P, McLachlan SA. Validation of the cancer needs questionnaire (CNQ) short-form version in an ambulatory cancer setting. Qual Life Res 2004;13:1225-33. (Pubitemid 39149606)
13. Holladay JT. Visual acuity measurements. J Cataract Refract Surg 2004;30:287-90. (Pubitemid 38366348)
14. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 2001;119:1050-58. (Pubitemid 32652197)
15. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
16. Mohamed NE, Bovbjerg DH, Montgomery GH, et al. Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific quality of life among patients with localized prostate cancer. Urol Oncol 2011;30:804-12.
17. Stommel M, Given BA, Given CW, et al. Gender bias in the measurement properties of the center for epidemiologic studies depression scale (CES-D). Psychiatry Res 1993;49:239-50. (Pubitemid 24046092)
18. Costanzo ES, Ryff CD, Singer BH. Psychosocial adjustment among cancer survivors: findings from a national survey of health and well-being. Health Psychol 2009;28:147-56.
19. Damato B. Disease and "dis-ease" in patients with uveal melanoma. Br J Ophthalmol 2000;84:343-44. (Pubitemid 30255479)